Gabelli Healthcare & Wellnessrx Trust Form 4 insider transactions
Insider transactions: buys and sells by directors, officers and ten percent owners, filed within two business days of the trade.
NYSE
Saba Capital Management, L.P. reported changes in beneficial ownership of Gabelli Healthcare & WellnessRx Trust common stock on August 11, 2026.
NYSE
Mario J. Gabelli, a director and control person, increased his indirect beneficial ownership in Gabelli Healthcare & WellnessRx Trust through purchases totaling 4,810 common shares.
NYSE
Mario J. Gabelli, a director and 10% owner, increased his direct and indirect holdings in Gabelli Healthcare & WellnessRx Trust by purchasing 990 common shares.
NYSE
Mario J. Gabelli, a director and 10% owner of Gabelli Healthcare & WellnessRx Trust, reported significant net acquisitions of Series E Cumulative Preferred Shares.
NYSE
Mario J. Gabelli reports significant changes in beneficial ownership of Gabelli Healthcare & WellnessRx Trust Series G Cumulative Preferred Shares.
NYSE
Saba Capital Management, L.P., a 10% owner, increased its indirect beneficial ownership in Gabelli Healthcare & WellnessRx Trust through recent common stock acquisitions.
NYSE
Mario J. Gabelli, a director and control person of the adviser, increased his direct beneficial ownership in Gabelli Healthcare & WellnessRx Trust by purchasing 2,500 common shares.
NYSE
A director of Gabelli Healthcare & WellnessRx Trust reported multiple pre-scheduled sales of common shares totaling 9,000 units in late 2025.
NYSE
Saba Capital Management, L.P., a 10% owner, acquired an additional 14,451 shares of Gabelli Healthcare & WellnessRx Trust common stock at $9.62 per share.
NYSE
Mario J. Gabelli, a Director and 10% owner, reported a net acquisition of 1.6 million Series G Cumulative Preferred Shares of Gabelli Healthcare & WellnessRx Trust through affiliated entities.
NYSE
Saba Capital Management, L.P., a 10% owner of Gabelli Healthcare & WellnessRx Trust, reported a planned acquisition of 20,808 common shares.
NYSE
Saba Capital Management, L.P., a 10% owner, reported acquiring additional common stock in Gabelli Healthcare & WellnessRx Trust through open market purchases.
NYSE
Saba Capital Management, a 10% owner and director, increased its beneficial ownership in Gabelli Healthcare & WellnessRx Trust through recent common stock purchases.
NYSE
Saba Capital Management, L.P. reported acquiring additional common stock in Gabelli Healthcare & WellnessRx Trust through a pre-arranged 10b5-1 plan.
NYSE
Saba Capital Management, L.P. and Boaz Weinstein reported an acquisition of 11,330 common shares of Gabelli Healthcare & WellnessRx Trust, increasing their indirect beneficial ownership to 2,037,156 shares.
NYSE
Saba Capital Management, L.P. and Boaz Weinstein reported an acquisition of 19,101 common shares of Gabelli Healthcare & WellnessRx Trust at $9.43 per share.
NYSE
Saba Capital Management, L.P., a 10% owner and director of Gabelli Healthcare & WellnessRx Trust, has increased its stake in the company through a recent share purchase.
NYSE
Saba Capital Management, L.P., a 10% owner and director, reported the planned acquisition of 6,080 shares of Gabelli Healthcare & WellnessRx Trust common stock at $9.35 per share, increasing its indirect beneficial ownership to 1,993,801 shares.
NYSE
Form 4: Saba Capital Management and Boaz Weinstein Boost Holdings in Gabelli Healthcare & WellnessRx Trust
Saba Capital Management, L.P. and Boaz Weinstein, both 10% owners and directors, have increased their beneficial ownership in Gabelli Healthcare & WellnessRx Trust through recent open market purchases.
NYSE
Form 4: Mario J. Gabelli Reports Disposition of Preferred Shares in Gabelli Healthcare & WellnessRx Trust
Mario J. Gabelli, a Director and 10% owner of Gabelli Healthcare & WellnessRx Trust, reported the disposition of 10,000 Series G Cumulative Preferred Shares through a pre-arranged put option exercise.
NYSE
Mario J. Gabelli, a Director and 10% Owner of Gabelli Healthcare & WellnessRx Trust, reported a surrender of Series E Cumulative Preferred Shares to the fund at $10 per share, resulting in a beneficial ownership of 830,000 direct and 200,000 indirect shares.
NYSE
Saba Capital Management, L.P. reports purchasing 1,000 shares of Gabelli Healthcare & WellnessRx Trust (GRX) at $9.33 per share, increasing its indirect holdings.
NYSE
Saba Capital Management, a 10% owner and director, increases its holdings in Gabelli Healthcare & WellnessRx Trust (GRX) through a recent purchase of common stock.
NYSE
Saba Capital Management, L.P. reports acquiring additional shares of Gabelli Healthcare & WellnessRx Trust (GRX), increasing its beneficial ownership.
NYSE
Saba Capital Management, a 10% owner and director in Gabelli Healthcare & WellnessRx Trust, reports the acquisition of 1,600 shares of common stock at $9.47 per share.
NYSE
Saba Capital Management, a 10% owner and director, increased its indirect holdings in Gabelli Healthcare & WellnessRx Trust by purchasing 1,100 shares of common stock at $9.24 per share on April 11, 2025.
NYSE
Saba Capital Management, L.P. reports acquiring 13,156 shares of Gabelli Healthcare & WellnessRx Trust at $9.62 per share, increasing its total holdings to 1,969,644 shares.
NYSE
Saba Capital Management, a 10% owner and director, reports purchasing additional shares of Gabelli Healthcare & WellnessRx Trust (GRX) common stock.
NYSE
Saba Capital Management reports purchasing 100 shares of Gabelli Healthcare & WellnessRx Trust (GRX) common stock at $10.09 per share, increasing their total holdings to 1,955,939 shares.
NYSE
Saba Capital Management, L.P. reports acquiring additional shares of Gabelli Healthcare & WellnessRx Trust, increasing its beneficial ownership.